New Approach to VNS Therapy

The Food and Drug Adminstration (FDA) has approved a new generator for the VNS Therapy^® System. The new generator, called AspireSR^®, offers the ability to provide automatic stimulation in response to increased heart rate, in addition to its other stimulation timing. Since heart rate increases are seen prior to many seizures, the ability to provide stimulation at these times provides a way to respond directly at the time of a seizure. “AspireSR^® expands the use of VNS Therapy to a responsive type of stimulation, which is the logical next step in devices for epilepsy,” commented Nathan Foundation, chair of the Epilepsy Foundation's Professional Advisory Board.

• News Release, "Cyberonics Announces FDA Approval Of The AspireSR® Generator For VNS Therapy®"
• VNS Therapy System and the AspireSR^® is from Cyberonics (now know as LivaNova).
• Learn more about VNS Therapy on the treatment section of epilepsy.com.